The North American non-invasive aesthetic treatment market size was estimated at USD 16.21 billion in 2025 and is projected to be worth around USD 30.43 billion by 2035, growing at a CAGR of 6.5% from 2026 to 2035. The market growth is driven by rising demand for low risk cosmetic enhancement and changing lifestyle preferences.

North America Non-Invasive Aesthetic Treatment Market Statical Scope

North America benefits from a dense network of dermatology clinics and medical spas offering procedures like injectables, lasers, and body contouring. The social media and growing acceptance of cosmetics enhancement continue to normalise these beauty enhancement treatments across the region. The MedSpa subscription model is highly adopted in cities such as New York and Los Angeles. The growth of the non-invasive aesthetic treatment market is supported by strong consumer spending and early adoption of new technologies.

North America Non-Invasive Aesthetic Treatment Market Share, By Type, 2025, (%)

• Injectables - Injectables lead the segment, with a share of 46%, driven by high demand for minimally invasive treatments such as botulinum toxin and dermal fillers, offering quick results with minimal downtime.
• Skin Rejuvenation - Skin Rejuvenation holds a significant portion, with a share of 34%, driven by growing consumer interest in anti-ageing treatments, laser therapies, and overall skin enhancement solutions.
• Others - Others account for a notable share, with a share of 20%, driven by a mix of emerging and niche non-invasive aesthetic procedures catering to diverse cosmetic needs.

North America Non-Invasive Aesthetic Treatment Market Share, By End-Use, 2025, (%)

• Hospital / Surgery Centre - Hospital/Surgery Centres account for a notable share, with a share of 18%, driven by the availability of advanced infrastructure and expertise for more complex non-invasive procedures.
• MedSpa - MedSpa holds a significant portion, with a share of 32%, supported by the rising popularity of wellness-oriented aesthetic services and convenient, non-clinical environments.
• Traditional Spa – Traditional Spas represent a smaller segment, with a share of 15%, constrained by limited medical-grade offerings despite steady demand for basic aesthetic services.
• HCP Owned Clinic - HCP Owned Clinics lead the segment, with a share of 35%, driven by increasing patient preference for medically supervised aesthetic procedures and personalized treatment plans.

Top Companies in the North America Non-Invasive Aesthetic Treatment Market

• Hologic, Inc.
• Allergan, Inc.
• Galderma S.A.
• Alma Lasers
• Syneron Candela
• Johnson & Johnson
• MerzPharma
• Lumenis
• Solta Medical
• Cutera Inc.
• Revance Therapeutics Inc.

Segments Covered in the Report

By Procedure

• Injectables
  • Botulinum Toxin
  • Calcium Hydroxylapatite
  • Hyaluronic Acid
  • Polymer Filler
  • Collagen
• Skin Rejuvenation
  • Chemical Peel
  • Laser Skin Resurfacing
  • Photorejuvenation
  • Other Skin Rejuvenation Procedures
• Others
  • Hair Removal
  • Nonsurgical Fat Reduction
  • Sclerotherapy
  • Cellulite Treatment

By End Use

• Hospital/Surgery Center
• MedSpa
• Traditional Spa
• HCP owned clinic